This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Angstrom Pharmaceuticals, Inc.. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Innovations by Malcolm Finlayson
Introduction
Malcolm Finlayson is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of biomedical research, particularly in the modulation of cell signaling pathways. With a total of two patents to his name, Finlayson's work focuses on addressing diseases characterized by aberrant cell migration and invasion.
Latest Patents
Finlayson's latest patents include innovative methods for treating and diagnosing conditions related to abnormal cell behavior. One patent describes a method of treating diseases by administering a peptide that modulates the FAK signal transduction pathway. This approach aims to effectively manage conditions associated with aberrant cell migration. Another patent outlines compositions and methods for modulating cell migration, utilizing peptides that activate CD44. These advancements hold promise for improving therapeutic strategies in the biomedical field.
Career Highlights
Finlayson is currently associated with Angstrom Pharmaceuticals, Inc., where he continues to develop groundbreaking solutions in the realm of cell signaling. His expertise and dedication to research have positioned him as a key figure in his field.
Collaborations
Finlayson collaborates with Bassam Damaj, contributing to the advancement of their shared research goals. Their partnership enhances the potential for innovative discoveries in the biomedical sector.
Conclusion
Malcolm Finlayson's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for new therapeutic approaches to complex diseases.